Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van Hage

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
The European Respiratory Journal|March 3, 2009
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged miceL Swedin, T Neimert-Andersson, J Hjoberg, et al.
Clinical and Experimental Immunology|July 11, 2012
Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel diseaseJ Grundström, L Linton, S Thunberg, et al.
The Journal of Allergy and Clinical Immunology|November 7, 1999
Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen seasonM van Hage-Hamsten, M Kronqvist, O Zetterström, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 22, 2016
Subpollen particles are rich carriers of major short ragweed allergens and NADH dehydrogenases: quantitative proteomic and allergomic studyK Smiljanic, D Apostolovic, S Trifunovic, et al.
Allergy|October 18, 2015
Parental smoking and development of allergic sensitization from birth to adolescenceJ D Thacher, O Gruzieva, G Pershagen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 10, 2002
Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitisM van Hage-Hamsten, E Johansson, A Roquet, et al.
International Archives of Allergy and Immunology|October 26, 1999
Evaluation of specific IgE to the recombinant group 2 mite allergens Lep d 2 and Tyr p 2 in the Pharmacia CAP systemE Johansson, T L Eriksson, S Olsson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1992
Comparison of allergic responses to dust mites in U.K. bakery workers and Swedish farmersR D Tee, D J Gordon, M van Hage-Hamsten, et al.
Allergy|February 19, 2013
Identification of galactose-α-1,3-galactose in the gastrointestinal tract of the tick Ixodes ricinus; possible relationship with red meat allergyC Hamsten, M Starkhammar, T A T Tran, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2001
Cross-reactivity studies of a new group 2 allergen from the dust mite Glycyphagus domesticus, Gly d 2, and group 2 allergens from Dermatophagoides pteronyssinus, Lepidoglyphus destructor, and Tyrophagus putrescentiae with recombinant allergensG Gafvelin, E Johansson, A Lundin, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
The European Respiratory Journal|March 3, 2009
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged miceL Swedin, T Neimert-Andersson, J Hjoberg, et al.
Clinical and Experimental Immunology|July 11, 2012
Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel diseaseJ Grundström, L Linton, S Thunberg, et al.
The Journal of Allergy and Clinical Immunology|November 7, 1999
Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen seasonM van Hage-Hamsten, M Kronqvist, O Zetterström, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 22, 2016
Subpollen particles are rich carriers of major short ragweed allergens and NADH dehydrogenases: quantitative proteomic and allergomic studyK Smiljanic, D Apostolovic, S Trifunovic, et al.
Allergy|October 18, 2015
Parental smoking and development of allergic sensitization from birth to adolescenceJ D Thacher, O Gruzieva, G Pershagen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 10, 2002
Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitisM van Hage-Hamsten, E Johansson, A Roquet, et al.
International Archives of Allergy and Immunology|October 26, 1999
Evaluation of specific IgE to the recombinant group 2 mite allergens Lep d 2 and Tyr p 2 in the Pharmacia CAP systemE Johansson, T L Eriksson, S Olsson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1992
Comparison of allergic responses to dust mites in U.K. bakery workers and Swedish farmersR D Tee, D J Gordon, M van Hage-Hamsten, et al.
Allergy|February 19, 2013
Identification of galactose-α-1,3-galactose in the gastrointestinal tract of the tick Ixodes ricinus; possible relationship with red meat allergyC Hamsten, M Starkhammar, T A T Tran, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2001
Cross-reactivity studies of a new group 2 allergen from the dust mite Glycyphagus domesticus, Gly d 2, and group 2 allergens from Dermatophagoides pteronyssinus, Lepidoglyphus destructor, and Tyrophagus putrescentiae with recombinant allergensG Gafvelin, E Johansson, A Lundin, et al.
Pageof 17